Drug-Induced Dilated Cardiomyopathy Associated with Anagrelide.
10.4250/jcu.2008.16.4.130
- Author:
Seong Yoon KIM
1
;
Jang Young KIM
;
Young Jin YOUN
;
Nam Seok LEE
;
Min Soo AHN
;
Kyung Hoon LEE
;
Ho Young KIM
;
Kyung Hoon CHOE
Author Information
1. Division of Cardiology, Wonju College of Medicine, Yonsei University, Wonju, Korea. imjy@yonsei.ac.kr
- Publication Type:Case Report
- Keywords:
Anagrelide;
Cardiomyopathy
- MeSH:
Cardiomyopathies;
Cardiomyopathy, Dilated;
Quinazolines
- From:Journal of Cardiovascular Ultrasound
2008;16(4):130-132
- CountryRepublic of Korea
- Language:English
-
Abstract:
Anagrelide is an effective drug for essential thrombocythaemia, and its adverse cardiovascular effects are relatively rarely reported. We experienced a 73 year-old man with essential thrombocythaemia developed anagrelide-induced dilated cardiomyopathy. After discontinuation of anagrelide, the patient's left ventricular systolic function was completely recovered.
